149
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Service Utilization among Persons Who Inject Drugs Attending a Syringe Exchange Program in New York State

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Abdi, H., & Valentin, D. (2007). Multiple correspondence analysis. Encyclopedia of Measurement and Statistics, 2(4), 651–657.
  • ACR Health. (2022). ACR Health.
  • Artenie, A. A., Jutras-Aswad, D., Roy, É., Zang, G., Bamvita, J.-M., Lévesque, A., & Bruneau, J. (2015). Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: Room for improvement. Journal of Viral Hepatitis, 22(10), 792–799. https://doi.org/10.1111/JVH.12393
  • Barash, E. T., Hanson, D. L., Buskin, S. E., & Teshale, E. (2007). HIV-infected injection drug users: Health care utilization and morbidity. Journal of Health Care for the Poor and Underserved, 18(3), 675–686. https://doi.org/10.1353/HPU.2007.0053
  • Bayani, A., Ghiasvand, H., Rezaei, O., Fattah Moghaddam, L., Noroozi, A., Ahounbar, E., Higgs, P., & Armoon, B. (2020). Factors associated with HIV testing among people who inject drugs: A meta-analysis. Journal of Addictive Diseases, 38(3), 361–374. https://doi.org/10.1080/10550887.2020.1771235
  • Cisneros, G. O., Douaihy, A. B., & Kirisci, L. (2009). Access to healthcare among injection drug users at a needle exchange program in Pittsburgh, PA. Journal of Addiction Medicine, 3(2), 89–94. https://doi.org/10.1097/ADM.0B013E318185E71D
  • Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., Mattick, R. P., Hickman, M., & Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet. Global Health, 5(12), e1192–e1207. https://doi.org/10.1016/S2214-109X(17)30375-3
  • Djordjevic, F., Ryan, K., Gunn, J., Brener, L., O’Keefe, D., Draper, B., Schroeder, S., Gold, J., Treloar, C., Broady, T., Dietze, P., Hellard, M., & Pedrana, A. (2021). Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia. Journal of Viral Hepatitis, 28(12), 1738–1743. https://doi.org/10.1111/JVH.13612
  • Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5), 655–661. https://doi.org/10.2105/AJPH.86.5.655
  • Health People 2020. (2016). Access to health services.
  • Heinzerling, K. G., Kral, A. H., Flynn, N. M., Anderson, R. L., Scott, A., Gilbert, M. L., Asch, S. M., & Bluthenthal, R. N. (2006). Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvement. Drug and Alcohol Dependence, 81(2), 167–178. https://doi.org/10.1016/J.DRUGALCDEP.2005.06.008
  • Jacka, B. P., Janssen, T., Garner, B. R., Yermash, J., Yap, K. R., Ball, E. L., Hartzler, B., & Becker, S. J. (2021). Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder. Drug and Alcohol Dependence, 221, 108617. https://doi.org/10.1016/J.DRUGALCDEP.2021.108617
  • Kang, E. K., Yun, J., Hwang, S. H., Lee, H., & Lee, J. Y. (2022). The impact of the COVID-19 pandemic in the healthcare utilization in Korea: Analysis of a nationwide survey. Journal of Infection and Public Health, 15(8), 915–921. https://doi.org/10.1016/J.JIPH.2022.07.003
  • Kassambara, A., & Mundt, F. (2020). factoextra: Extract and visualize the results of multivariate data analyses. (R Package Version 1.0.7).
  • Knowlton, A. R., Hoover, D. R., Chung, S. E., Celentano, D. D., Vlahov, D., & Latkin, C. A. (2001). Access to medical care and service utilization among injection drug users with HIV/AIDS. Drug and Alcohol Dependence, 64(1), 55–62. https://doi.org/10.1016/S0376-8716(00)00228-3
  • Lê, S., Josse, J., & Husson, F. (2008). FactoMineR: A package for multivariate analysis. Journal of Statistical Software, 25(1), 1–18. https://doi.org/10.18637/jss.v025.i01
  • Lewer, D., Freer, J., King, E., Larney, S., Degenhardt, L., Tweed, E. J., Hope, V. D., Harris, M., Millar, T., Hayward, A., Ciccarone, D., & Morley, K. I. (2020). Frequency of health-care utilization by adults who use illicit drugs: A systematic review and meta-analysis. Addiction (Abingdon, England), 115(6), 1011–1023. https://doi.org/10.1111/ADD.14892
  • Lewer, D., Tweed, E. J., Aldridge, R. W., & Morley, K. I. (2019). Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks. Drug and Alcohol Dependence, 204, 107525. https://doi.org/10.1016/j.drugalcdep.2019.06.027
  • Lewis, R., Baugher, A. R., Finlayson, T., Wejnert, C., & Sionean, C. (2020). Healthcare access and utilization among persons who inject drugs in medicaid expansion and nonexpansion states: 22 United States Cities, 2018. The Journal of Infectious Diseases, 222(Suppl 5), S420–S428. https://doi.org/10.1093/INFDIS/JIAA337
  • Maragh-Bass, A. C., Powell, C., Park, J., Flynn, C., & German, D. (2017). Sociodemographic and access-related correlates of health-care utilization among African American injection drug users: The BESURE study. Journal of Ethnicity in Substance Abuse, 16(3), 344–362. https://doi.org/10.1080/15332640.2016.1196629
  • Martin, R. E., Remple, V., Gold, F., Berkowitz, J., Murphy, W., & Money, D. (2005). Drug use and risk of bloodborne infections: A survey of female prisoners in British Columbia. Canadian Journal of Public Health, 96(2), 97–101. https://doi.org/10.1007/BF03403669
  • Masson, C. L., Sorensen, J. L., Perlman, D. C., Shopshire, M. S., Delucchi, K. L., Chen, T. C., Sporer, K., Des Jarlais, D., & Hall, S. M. (2007). Hospital-versus community–based syringe exchange: A randomized controlled trial. AIDS Education and Prevention, 19(2), 97–110. https://doi.org/10.1521/AEAP.2007.19.2.97
  • Mathers, B. M., Degenhardt, L., Bucello, C., Lemon, J., Wiessing, L., & Hickman, M. (2013). Mortality among people who inject drugs: A systematic review and meta-analysis. Bulletin of the World Health Organization, 91(2), 102–123. https://doi.org/10.2471/BLT.12.108282
  • McKnight, C., Shumway, M., Masson, C. L., Pouget, E. R., Jordan, A. E., Des Jarlais, D. C., Sorensen, J. L., & Perlman, D. C. (2017). Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization. Journal of Ethnicity in Substance Abuse, 16(4), 404–419. https://doi.org/10.1080/15332640.2017.1292418
  • Miller-Lloyd, L., Landry, J., Macmadu, A., Allard, I., & Waxman, M. (2020). Barriers to healthcare for people who inject drugs: A survey at a syringe exchange program. Substance Use & Misuse, 55(6), 896–899. https://doi.org/10.1080/10826084.2019.1710207
  • Mizuno, Y., Wilkinson, J. D., Santibanez, S., Dawson Rose, C., Knowlton, A., Handley, K., & Gourevitch, M. N. (2006). Correlates of health care utilization among HIV-seropositive injection drug users. AIDS Care – Psychological and Socio-Medical Aspects of AIDS/HIV, 18(5), 417–425. https://doi.org/10.1080/09540120500162247
  • Murphy, S. M., Yoder, J., Pathak, J., & Avery, J. (2021). Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic. Journal of Substance Abuse Treatment, 121, 108177. https://doi.org/10.1016/J.JSAT.2020.108177
  • Nambiar, D., Stoové, M., & Dietze, P. (2014). A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs. BMC Health Services Research, 14(1), 308–307. https://doi.org/10.1186/1472-6963-14-308/TABLES/2
  • Nassau, T., Kolla, G., Mason, K., Hopkins, S., Tookey, P., McLean, E., Werb, D., & Scheim, A. (2022). Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada. Harm Reduction Journal, 19(1), 1–8. https://doi.org/10.1186/S12954-022-00610-Y/TABLES/2
  • Okoro, O., Vosen, E. C., Allen, K., Kennedy, J., Roberts, R., & Aremu, T. (2022). COVID-19 impact on mental health, healthcare access and social wellbeing – A black community needs assessment. International Journal for Equity in Health, 21(1), 137. https://doi.org/10.1186/s12939-022-01743-z
  • Parker, M. A., Zoh, R. S., Nelson, E. J., & Owora, A. H. (2021). Correlates of disparities in syringe return ratios: A cross-sectional study of a syringe services program in New York. Journal of Substance Abuse Treatment, 121, 108193. https://doi.org/10.1016/J.JSAT.2020.108193
  • Pollack, H. A., Khoshnood, K., Blankenship, K. M., & Altice, F. L. (2002). The impact of needle exchange–based health services on emergency department use. Journal of General Internal Medicine, 17(5), 341–348. https://doi.org/10.1046/j.1525-1497.2002.10663.x
  • R Core Team. (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing.
  • Riley, E. D., Wu, A. W., Junge, B., Marx, M., Strathdee, S. A., & Vlahov, D. (2002). Health services utilization by injection drug users participating in a needle exchange program. The American Journal of Drug and Alcohol Abuse, 28(3), 497–511. https://doi.org/10.1081/ADA-120006738
  • Roy, C. M., Brennan Bollman, E., Carson, L. M., Northrop, A. J., Jackson, E. F., & Moresky, R. T. (2021). Assessing the indirect effects of COVID-19 on healthcare delivery, utilization and health outcomes: A scoping review. European Journal of Public Health, 31(3), 634–640. https://doi.org/10.1093/EURPUB/CKAB047
  • Sherman, S. G., Patel, S. A., Ramachandran, D. V., Galai, N., Chaulk, P., Serio-Chapman, C., & Gindi, R. M. (2015). Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk. Drug and Alcohol Review, 34(6), 637–644. https://doi.org/10.1111/DAR.12276
  • Stopka, T. J., Hutcheson, M., & Donahue, A. (2017). Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: Qualitative findings from health navigators with the iDU (“I do”) care collaborative. Harm Reduction Journal, 14(1), 26. https://doi.org/10.1186/s12954-017-0151-4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.